AEPCX
Price
$57.74
Change
-$0.23 (-0.40%)
Updated
Jun 3 closing price
Net Assets
133.25B
SGQCX
Price
$40.89
Change
+$0.34 (+0.84%)
Updated
Jun 2 closing price
Net Assets
466.29M
Interact to see
Advertisement

AEPCX vs SGQCX

Header iconAEPCX vs SGQCX Comparison
Open Charts AEPCX vs SGQCXBanner chart's image
American Funds Europacific Growth C
Price$57.74
Change-$0.23 (-0.40%)
VolumeN/A
Net Assets133.25B
DWS International Growth C
Price$40.89
Change+$0.34 (+0.84%)
VolumeN/A
Net Assets466.29M
AEPCX vs SGQCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. SGQCX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and SGQCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. SGQCX (466M). SGQCX pays higher dividends than AEPCX: SGQCX (0.40) vs AEPCX (0.32). AEPCX was incepted earlier than SGQCX: AEPCX (24 years) vs SGQCX (24 years). SGQCX (2.17) is less costly to investors than AEPCX (1.59). AEPCX is a more actively managed with annual turnover of: 30.00 vs. SGQCX (7.00). AEPCX has a lower initial minimum investment than SGQCX: AEPCX (250) vs SGQCX (1000). SGQCX annual gain was more profitable for investors over the last year : 9.17 vs. AEPCX (1.80). SGQCX return over 5 years is better than : 18.88 vs. AEPCX (15.20).
AEPCXSGQCXAEPCX / SGQCX
Total Expense Ratio1.591.8785%
Annual Report Gross Expense Ratio1.592.1773%
Fund Existence24 years24 years-
Gain YTD11.74810.762109%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets133B466M28,541%
Annual Yield % from dividends0.320.4080%
Returns for 1 year1.809.1720%
Returns for 3 years14.7219.4976%
Returns for 5 years15.2018.8881%
Returns for 10 years19.4441.6647%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELTX8.080.33
+4.26%
Elicio Therapeutics
MBC10.200.38
+3.87%
MasterBrand
IOVA1.820.06
+3.41%
Iovance Biotherapeutics
VIVS1.770.02
+1.43%
VivoSim Lab Inc
SNN29.12-0.03
-0.10%
Smith & Nephew plc